Brainsway (BWAY) Change in Accured Expenses (2018 - 2026)
Brainsway (BWAY) posted quarterly Change in Accured Expenses of $563000.0 for Q1 2026, up 246.61% year-on-year from $162428.2 in Q1 2025, and up 149.12% on a QoQ basis from $226000.0 in Q4 2025.
Brainsway (BWAY) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Change in Accured Expenses for 9 consecutive years, with $563000.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Accured Expenses rose 246.61% year-over-year to $563000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 740.72% YoY) and the FY2025 annual result came in at $400000.0, up 210.08% from the prior year.
- Change in Accured Expenses grew to $563000.0 in Q1 2026 per BWAY's latest filing, from $226000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for BWAY reached as high as $1.3 million in Q3 2025 and fell as low as -$510000.0 in Q1 2022.
- A 5-year average of $193941.2 and a median of $226000.0 in 2025 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses plunged 3300.0% — and 2026, when it surged 246.61%.
- Year by year, Change in Accured Expenses stood at $731000.0 in 2022, then sank by 42.82% to $418000.0 in 2023, then slumped by 51.44% to $203000.0 in 2024, then gained by 11.33% to $226000.0 in 2025, then surged by 149.12% to $563000.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $563000.0, $226000.0, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 563,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 563,000.00 |
| Mar 31, 2026 | 563,000.00 |
| Dec 31, 2025 | 226,000.00 |
| Dec 31, 2025 | 226,000.00 |
| Sep 30, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | -261,000.00 |
| Jun 30, 2025 | -261,000.00 |
| Mar 31, 2025 | -384,000.00 |
| Mar 31, 2025 | -384,000.00 |
| Dec 31, 2024 | 203,000.00 |
| Dec 31, 2024 | 203,000.00 |
| Sep 30, 2024 | 456,000.00 |
| Sep 30, 2024 | 456,000.00 |
| Jun 30, 2024 | -54,000.00 |
| Jun 30, 2024 | -54,000.00 |
| Mar 31, 2024 | -57,000.00 |
| Mar 31, 2024 | -57,000.00 |
| Dec 31, 2023 | 418,000.00 |
| Dec 31, 2023 | 418,000.00 |